Study details
Enrolling now
DRonabinol Treatment of OSA
VA Office of Research and Development
NCT IDNCT06477952ClinicalTrials.gov data as of Apr 2026
Phase
Phase 1/2
Target enrollment
120
Study length
about 1.4 years
Ages
≤65
Locations
1 site in IL
What this study is about
This trial is testing if Dronabinol can help treat obstructive sleep apnea (OSA). Participants will take oral Dronabinol for two weeks, and their sleep studies will be monitored before and after treatment to see how it affects the severity of OSA.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Take Dronabinol
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Oral
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Drug classes
dronabinol
Drug routes
oral (Oral Capsule)
Endpoints
Primary: Apnea hypopnea index (AHI)